pieris.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi PIRS
Pieris Pharmaceuticals (PIRS) protects its business through Anticalin patents, although capital restructuring has temporarily weakened its market position. Pieris Pharmaceuticals (PIRS) is implementing ESG standards in protein production to ensure ethical testing. Stephen Yarrow is currently reviewing the drug portfolio in search of new partners. Absolute operating profit reflects the cash flow dynamics, with the metric standing at 0.00, allowing for a real-time assessment of the issuer's current financial stability.
Ringkesan rincian data analitis Pieris Pharmaceuticals, Inc. (PIRS)
- nilai pasar lan prakiraan target analis:
- rincian nilai pasar emiten:
- statistik nilai buku emiten:
- rincian struktur utang lan likuiditas bisnis:
Rasio Kabeh Utang marang Dana Pribadi Pieris Pharmaceuticals|PIRS - Utang jangka dawa marang ekuitas|Kewajiban jangka cendhak marang ekuitas Pieris Pharmaceuticals Inc|PIRS - Gunggung utang perusahaan|Utang-utang marang aset resik Pieris Pharmaceuticals|PIRS - Utang jangka dawa perusahaan|Utang jangka cendhak Pieris Pharmaceuticals|Rasio jangkoan perantara pieris.com
- statistik bathi lan rasio pasar:
PIRS - Bathi resik|Prakiraan bathi perusahaan Pieris Pharmaceuticals|PIRS - Rasio rega marang bathi|Kapitalisasi marang proyeksi bathi pieris.com|PIRS - Pangali rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Pieris Pharmaceuticals|PIRS - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi saben siji saham sajrone 12 wulan pungkasan Pieris Pharmaceuticals|PIRS - Bathi resik saben saham (EPS TTM)|Wutah bathi saben siji saham taun-ka-taun sajrone 12 wulan pungkasan pieris.com|PIRS - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep Pieris Pharmaceuticals
Ringkesan analitik perusahaan:PIRS Pieris Pharma
Pieris Pharmaceuticals (PIRS) focuses on R&D, outsourcing the production of protein drugs to external contract manufacturing organizations to minimize capital expenditures. This specific operational model is reflected in the company's EBITDA, which captures the net cash flow from core operations before interest and depreciation, allowing investors to identify hidden cost increases behind one-time spikes in the curve and assess the real stability of the capital.
Karo sapa Pieris Pharmaceuticals saingan
Haleon Corp (HLN) - Bathi sadurunge bunga, pajak, lan amortisasi|KVUE: Bathi operasional sadurunge ngurangi amortisasi|veronapharma.com - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|MENS: Bathi operasional EBITDA|Ligand Pharmaceuticals Incorporated - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|AMRX (Amneal Pharmaceuticals Inc) - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Perrigo Corp PRGO|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Alvotech (ALVO)|LQDA (liquidia.com) - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Galapagos GLPG|ANIP (ANI Pharmaceuticals Inc) - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|MannKind Corp. - Bathi operasional EBITDA|Pendapatan operasional sadurunge ngurangi amortisasi Amphastar Corp AMPH|PCRX: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi ars-pharma.com (SPRY)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Theravance Biopharma, Inc.|AQST: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA SCPH|Pendapatan operasional sadurunge ngurangi amortisasi tectonictx.com|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Tonix Pharmaceuticals TNXP|Pendapatan operasional sadurunge ngurangi amortisasi SXT Pharmaceuticals (SXTC)|EPRX: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi BHST (BioHarvest Sciences, Inc.)|Invizyne Technologies, Inc. (EXOZ) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi ORMP (Oramed Pharmaceuticals Inc.)|ENTX (Entera Bio Ltd) - Bathi operasional EBITDA|HYFT: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi operasional EBITDA ABVC|Bathi operasional EBITDA Cumberland Pharmaceuticals Inc (CPIX)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Quantum BioPharma Limited QNTM|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi FGEN|TELO - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Rani Therapeutics (RANI) - Bathi operasional sadurunge ngurangi amortisasi|SNYR: Bathi operasional EBITDA|Rallybio (RLYB) - Bathi operasional EBITDA|LEXX (Lexaria Bioscience Corp) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi Pulmatrix Corporation (PULM)|Bathi operasional EBITDA PTHL|APM - Bathi sadurunge bunga, pajak, lan amortisasi|Lyra Therapeutics - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Impact BioMedical, Inc. IBO|TNFA: Bathi operasional sadurunge ngurangi amortisasi|cbdMD, Inc. - Bathi perusahaan sadurunge pajak, bunga, lan amortisasi|PRFX: Bathi operasional EBITDA|CYTO - Pendapatan operasional sadurunge ngurangi amortisasi|LIPO (Lipella Pharmaceuticals, Inc.) - Bathi operasional EBITDA|Bathi operasional sadurunge ngurangi amortisasi OptiNose Inc (OPTN)|Bathi operasional EBITDA PROC|Bathi operasional EBITDA Petros Pharma (PTPI)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Qilian International QLI|acelyrin.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|TFFP - Bathi sadurunge mbayar bunga, pajak, lan amortisasi
